Search results

Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
Author(s): Lori L McMullan , Gaston Vergara , Nassir F Marrouche Added: 3 years ago
Atrial fibrillation (AF) and heart failure (HF) are two disease conditions that are intimately intertwined, both pathophysiologically and clinically. Currently, over 2.3 million people in North America and 4.5 million in the EU have AF, making it the most common arrhythmia encountered in clinical practice.1,2 It is expected that by 2050 there will be over 10 million people with AF.3 The estimated… View more

Imaging & Diagnostics

Heart Failure
Author(s): Harry Crijns Added: 3 years ago
Atrial fibrillation (AF) is the most common arrhythmia. It takes the form of a rapid and irregular heartbeat and pulse rate, and predominantly affects the older population. AF is particularly prevalent in patients with cardiac disease. Patients suffering from AF largely fall into two categories: the elderly with cardiovascular (CV) complications or the young with intrinsic electrical disease. An… View more

Electrophysiology & Arrhythmia
Author(s): Todd D Miller , J Wells Askew Added: 3 years ago
Case Study A 47-year-old male truck driver with no previous history of heart disease presents for his annual Department of Transportation physical. He has noticed mild dyspnoea when climbing stairs but not with other activities of daily living. He denies chest discomfort, palpitations, orthopnoea, paroxysmal nocturnal dyspnoea or ankle oedema. His risk factors for coronary artery disease (CAD)… View more

Imaging & Diagnostics

Electrophysiology & Arrhythmia
EHRA 22: Atrial Fibrillation Ablation in Patients with Heart Failure
Author(s): Dhiraj Gupta Added: 2 years ago
In this short video interview filmed at EHRA 2022, Dr Dhiraj Gupta (Liverpool Heart and Chest NHS Foundation Trust, UK) discusses research surrounding atrial fibrillation in heart failure, and the considerations that must be taken when approaching AF ablation. Discussion points: Research surrounding atrial fibrillation in heart failure Conflicts in this research Further research required … View more

Electrophysiology & Arrhythmia
Author(s): Raffaele De Caterina , Giulia Renda Added: 3 years ago
Limitations of Coumarin Derivatives in Atrial Fibrillation and the Quest for New Drugs Warfarin and similar coumarin derivatives (vitamin K antagonists [VKAs]) clearly have the greatest efficacy among the currently available treatments (mostly aspirin) in preventing stroke in atrial fibrillation (AF).1 However, they carry a substantial risk of major bleeding (approximately 1.2% per year) and… View more

Anticoagulation

Electrophysiology & Arrhythmia
Author(s): Dipen Shah Added: 3 years ago
Since the first description of catheter ablation for focally initiated atrial fibrillation and focal atrial fibrillation in 1995, the popularity of this catheter intervention has grown practically exponentially and the ablation strategy underlying the intervention has evolved considerably. From ‘point’ ablation within the pulmonary venous vasculature,1 ablation has progressed through circular… View more

Electrophysiology & Arrhythmia
AHA 22: EAST-AFNET4: Rhythm Control Therapy in Atrial Fibrillation
Author(s): Shino Kany Added: 1 year ago
AHA 22 - Dr Shino Kany (Broad Institute of MIT and Harvard, Cambridge, MA, US) joins us to discuss the association of genetic risk and outcomes in patients receiving early rhythm control therapy for atrial fibrillation in the EAST-AFNET 4 trial. EAST-AFNET 4 aimed to compare early rhythm control to usual care amongst patients with a recent diagnosis of atrial fibrillation, randomised in a 1:1… View more

Electrophysiology & Arrhythmia
Redefining the Standard for Atrial Fibrillation: A Patient-centric Report
Author(s): Carina Blomström-Lundqvist , Helmut Pürerfellner , Alex White , et al Added: 3 years ago

Anticoagulation

Electrophysiology & Arrhythmia
ESC 23: The SurHyb Trial
Author(s): Alan Bulava Added: 7 months ago
ESC 2023 — Dr Alan Bulava (Ceske Budejovice Hospital and University of South Bohemia, CZ) joins us in this succinct interview to discuss the findings from the SurHyb trial. The SurHyb study was a prospective, open-label-multicentre randomized trial. The study aimed to evaluate CryoMaze surgery alone, as compared to CryoMaze followed by radiofrequency catheter ablation 3-months post-surgery. … View more

Electrophysiology & Arrhythmia
ECR Podcast - Ep 3: Atrial Fibrillation in Congenital Heart Disease
Author(s): Irene Martín de Miguel Added: 2 years ago
Did you know that atrial arrhythmias are the most common complication in adults with congenital heart disease? Dr Irene Martin de Miguel (Adult Congenital Heart Disease Fellow at Mayo Clinic Rochester, US) joins us in this featured author episode to outline her recent review article, Atrial Fibrillation in Congenital Heart Disease. In this podcast, Dr Martinde Miguel provides an overview of the… View more

Electrophysiology & Arrhythmia

CV Disease in Special Populations